v3.26.1
Financial Instruments
6 Months Ended
Jun. 30, 2026
Investments, All Other Investments [Abstract]  
Financial Instruments

7. Financial Instruments

 

Cash, Cash Equivalents, Restricted Cash and Marketable Securities

 

The following tables show the Company’s cash, cash equivalents, restricted cash, and marketable securities by significant investment category as of:

   June 30, 2026 
   Cost   Unrealized
Gain/(Loss)
   Fair
Value
   Cash and Cash
Equivalents
   Marketable
Securities
 
Cash  $4,013,000   $-   $4,013,000   $4,013,000   $- 
Restricted Cash   -    -    -    -    - 
Level 1                         
Money Market Funds   55,000    -    55,000    55,000    - 
Marketable Securities   16,511,000    (13,702,000)   2,809,000    -    2,809,000 
Total  $20,579,000   $(13,702,000)  $6,877,000   $4,068,000   $2,809,000 

 

   December 31, 2025 
   Adjusted
Cost
   Unrealized
Gain/(Loss)
   Fair
Value
   Cash and Cash
Equivalents
   Marketable
Securities
 
Cash  $4,981,000   $-   $4,981,000   $4,981,000   $- 
Restricted Cash   100,000    -    100,000    100,000    - 
Level 1                         
Money Market Funds   1,233,000    -    1,233,000    1,233,000    - 
Marketable Securities   26,383,000    (17,172,000)   9,211,000    -    9,211,000 
Total  $32,697,000   $(17,172,000)  $15,525,000   $6,314,000   $9,211,000 

 

The Company typically invests with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. Fair values were determined for each individual security in the investment portfolio.